Results 31 to 40 of about 1,077,776 (301)
Industry Payments to Physicians and Prescribing of Brand-name Drugs [PDF]
Under the Open Payments program (the Physician Payment SunshineAct,which ispartof theAffordableCareAct), theCenters forMedicareM clearly theybelieve that billions of dollars of investments will have good returns. In this issue of JAMA Internal Medicine, DeJong and colleagues,1 using 2013 data from the Open Payments programandprescribingdata for ...
openaire +2 more sources
Clinical Governing Non-Medical Prescribing in an NHS Trust: Issues for Consideration in Mental Health and Learning Disability [PDF]
The Department of Health (2006a) assert that Non-Medical Prescribing (NMP) has provided patients with faster access to medicines, improved access to health services and made better use of health professionals’ skills since it’s inception over a decade ...
Mills, Val
core +2 more sources
Difference in rural and urban Medicare prescription pattern for Parkinson’s disease in Hawai‘i
Background: Medical management of Parkinson’s Disease (PD) is becoming complex. Increasing evidence suggests that patients have better outcomes when they are managed by neurologists. However, access to neurologists can be limited in rural areas. Analysis
Michiko K. Bruno +7 more
doaj +1 more source
Objectives: The study was conducted with the aim to evaluate the prescribers’ approach of interaction with medical representatives for drug promotion. Methods: An explanatory, cross-sectional design was used to evaluate prescribers’ interactions with ...
Fatima, Bilqees +5 more
core +1 more source
ABSTRACT Background Chronic micro‐inflammation in patients with end‐stage renal disease (ESRD) is a significant driver of cardiovascular complications and diminished quality of life. While standard hemodialysis (SHD) effectively manages small‐molecule clearance, its ability to remove medium‐to‐large uremic toxins—the primary catalysts of systemic ...
Hongwei Zuo +5 more
wiley +1 more source
Background While many new medications may offer advantages over existing drugs, some newer drugs are reformulations of existing products that provide little innovation or incremental benefit while driving up drug costs.
Manvi Sharma +4 more
doaj +1 more source
Association of Industry Payments to Physicians With the Prescribing of Brand-name Statins in Massachusetts [PDF]
Pharmaceutical industry payments to physicians may affect prescribing practices and increase costs if more expensive medications are prescribed.Determine the association between industry payments to physicians and the prescribing of brand-name as compared with generic statins for lowering cholesterol.Cross-sectional linkage of the Part D Medicare ...
James S, Yeh +4 more
openaire +2 more sources
ABSTRACT Introduction This final analysis of a multicenter, prospective postmarketing surveillance study evaluated the safety of daprodustat in patients with chronic kidney disease anemia in routine clinical practice in Japan. Methods Patients who initiated daprodustat between September 2020 and July 2022 were registered.
Tadao Akizawa +7 more
wiley +1 more source
Kefyalew Ayalew Getahun,1 Adugnaw Sitotie Redia,2 Tezera Jemere Aragaw1 1Department of Pharmacology, School of Pharmacy, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia; 2Department of Clinical Pharmacy, School of Pharmacy,
Ayalew Getahun K +2 more
doaj
Background Generic drug substitution is a public health policy challenge with high economic potential. Generic drugs are generally cheaper than brand-name drugs. Drugs are a significant part of the total health expenditure, especially in ambulatory care.
Virgil Beauvais +6 more
doaj +1 more source

